Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.52 |
| ▸ | HTR2B | P41595 | 2/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | GABRA1 | P14867 | 6/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.46 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29849603 | 1.00 | LMNA (0.52) | LMNATRPA1SLC6A2HTR2BCHRM1 | |
| SCHEMBL15011592 | 0.83 | LMNA (0.50) | LMNATRPA1SLC6A2HTR2BCHRM1 | |
| SCHEMBL11038353 | 0.83 | GABRA1 (0.52) | LMNATRPA1SLC6A2HTR2BCHRM1 | |
| SCHEMBL6741099 | 0.82 | TRPA1 (0.39) | LMNATRPA1SLC6A2HTR2BCHRM1 | |
| SCHEMBL31438162 | 0.81 | LMNA (0.48) | LMNATRPA1SLC6A2HTR2BCHRM1 | |
| SCHEMBL1981588 | 0.81 | LMNA (0.48) | LMNATRPA1SLC6A2HTR2BCHRM1 | |
| SCHEMBL1487374 | 0.81 | LMNA (0.48) | LMNATRPA1SLC6A2HTR2BCHRM1 | |
| SCHEMBL15553081 | 0.79 | LMNA (0.47) | LMNATRPA1SLC6A2HTR2BCHRM1 | |
| SCHEMBL22991520 | 0.79 | LMNA (0.47) | LMNATRPA1SLC6A2HTR2BCHRM1 | |
| SCHEMBL30345312 | 0.78 | GABRA1 (0.62) | LMNATRPA1SLC6A2HTR2BCHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118460056-A | Anti-condensation material applied to basement | 江苏融匠防水材料有限公司 | 2024-08-09 | — | — | CN | claimed |
| US-20240115488-A1 | COMPOSITION FOR ORAL CAVITY CARE | ICHIMARU PHARCOS CO., LTD. (JP) | 2024-04-11 | — | — | US | claimed |
| CN-117157053-A | Oral care composition | 一丸自然美健有限公司 | 2023-12-01 | — | — | CN | claimed |
| CN-118460056-A | Anti-condensation material applied to basement | 江苏融匠防水材料有限公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-118460056-A | Anti-condensation material applied to basement | 江苏融匠防水材料有限公司 | 2024-08-09 | — | — | CN | disclosed |
| US-20240115488-A1 | COMPOSITION FOR ORAL CAVITY CARE | ICHIMARU PHARCOS CO., LTD. (JP) | 2024-04-11 | — | — | US | disclosed |
| CN-117157053-A | Oral care composition | 一丸自然美健有限公司 | 2023-12-01 | — | — | CN | disclosed |
| US-7202359-B2 | Azaoxa heterocyclic compound and method of preparing the same | CHANG CHUN PLASTICS CO., LTD. (TW) | 2007-04-10 | — | — | US | disclosed |
| US-20050085634-A1 | Azaoxa heterocyclic compound and method of preparing the same | CHANG CHUN PLASTICS CO., LTD. (TW) | 2005-04-21 | — | — | US | disclosed |
| US-20040068084-A1 | Azaoxa heterocyclic compound and method of preparing the same | CHANG CHUN PLASTICS CO., LTD. (TW) | 2004-04-08 | — | — | US | disclosed |
| EP-0202458-B1 | CROSS-LINKED POLYALKENYL PHENOL BASED PHOTORESIST COMPOSITIONS | International Business Machines Corporation (US) | 1992-03-25 | — | — | EP | disclosed |
| EP-0202458-A2 | Cross-linked polyalkenyl phenol based photoresist compositions | International Business Machines Corporation (US) | 1986-11-26 | — | — | EP | disclosed |
| US-4600683-A | Cross-linked polyalkenyl phenol based photoresist compositions | INTERNATIONAL BUSINESS MACHINES CORP. (US) | 1986-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040068084-A1 | Azaoxa heterocyclic compound and method of preparing the same | AOX1, KDM1A, BMI1 | LMNA 2897/4885TRPA1 2463/4885SLC6A2 2459/4885 |
| US-20050085634-A1 | Azaoxa heterocyclic compound and method of preparing the same | AOX1, KDM1A, BMI1 | LMNA 3143/4885TRPA1 2367/4885SLC6A2 2204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.